Lung Cancer
C34
Cancer that begins in the lungs, the leading cause of cancer deaths globally.
Medicamentos usados para tratar esta condição
59 medicamentos
Trametinib
Mekinist
Lorlatinib
Lorbrena
Docetaxel Anhydrous
Docetaxel
Gemcitabine Hydrochloride
Gemcitabine
Pembrolizumab And Berahyaluronidase Alfa-Pmph
KEYTRUDA QLEX
Bevacizumab-Awwb
MVASI
Gefitinib
Gefitinib
Adagrasib
KRAZATI
Paclitaxel
Paclitaxel
Docetaxel
Docetaxel
Etoposide
Etoposide
Pemetrexed Disodium
PEMRYDI RTU
Brigatinib
Alunbrig
Vinorelbine
Vinorelbine
Amivantamab-Vmjw
Rybrevant
Paclitaxel Protein-Bound Particles
Paclitaxel protein-bound particles
Pralsetinib
Gavreto
Topotecan
Topotecan
Ensartinib
ENSACOVE
Tarlatamab-Dlle
IMDELLTRA (AMG757)
Zenocutuzumab
BIZENGRI
Ipilimumab
YERVOY
Gemcitabine
Gemcitabine
Pemetrexed
Pemfexy
Encorafenib
BRAFTOVI
Datopotamab Deruxtecan
DATROWAY
Crizotinib
Xalkori
Erlotinib Hydrochloride
Erlotinib
Erlotinib
Erlotinib
Bevacizumab-Maly
ALYMSYS
Alectinib Hydrochloride
ALECENSA
Cemiplimab-Rwlc
LIBTAYO
Capmatinib
TABRECTA
Dacomitinib
Vizimpro
Trilaciclib
COSELA
Bevacizumab-Adcd
Vegzelma
Paclitaxel (Aibumin-Bound)
Paclitaxel
Taletrectinib
IBTROZI
Porfimer Sodium
Photofrin
Osimertinib
TAGRISSO
Lurbinectedin
ZEPZELCA
Tremelimumab
IMJUDO
Binimetinib
MEKTOVI
Atezolizumab
TECENTRIQ
Bevacizumab-Nwgd
JOBEVNE
Topotecan Hydrochloride
topotecan hydrochloride
Etoposide Phosphate
ETOPOPHOS
Fam-Trastuzumab Deruxtecan-Nxki
Enhertu
Nivolumab And Hyaluronidase-Nvhy
OPDIVO QVANTIG
Selpercatinib
RETEVMO
Tepotinib Hydrochloride
TEPMETKO
Necitumumab
Portrazza
Durvalumab
IMFINZI
Pembrolizumab
KEYTRUDA
Bevacizumab
Avastin
Amivantamab And Hyaluronidase-Lpuj (Human Recombinant)
Rybrevant Faspro
Atezolizumab And Hyaluronidase-Tqjs
Tecentriq Hybreza
Bevacizumab-Bvzr
Zirabev
Pemetrexed Dipotassium
PEMETREXED DIPOTASSIUM
Related Conditions
Esta lista inclui usos aprovados pela FDA e usos off-label documentados na literatura clínica. Sempre consulte um profissional de saúde antes de iniciar ou alterar um medicamento.